"10.1371_journal.pone.0124133","plos one","2015-03-31T00:00:00Z","Darryl J Hill; Natalie J Griffiths; Elena Borodina; Clio A Andreae; Richard B Sessions; Mumtaz Virji","School of Cellular & Molecular Medicine, Medical Sciences Building, University Walk, University of Bristol, Bristol, BS8 ITD, United Kingdom; School of Biochemistry, Medical Sciences Building, University Walk, University of Bristol, Bristol, BS8 ITD, United Kingdom","Conceived and designed the experiments: DJH NJG EB RBS MV. Performed the experiments: DJH NJG EB RBS CAA. Analyzed the data: DJH NJG EB RBS MV CAA. Contributed reagents/materials/analysis tools: DJH NJG EB RBS MV CAA. Wrote the paper: DJH RBS MV.","The authors have the following interests. This study was partly funded by GlaxoSmithKline Biologicals, who also provided a bacterial strain used in the study. A patent was filed relating to the use of Msf as a vaccine antigen by MV (W02012/032169), however, this has not been maintained by the University of Bristol and has been assigned to GSK. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2015","03","Darryl J Hill","DJH",6,TRUE,5,5,6,3,TRUE,TRUE,FALSE,0,NA,FALSE
